Enliven Therapeutics shares owned by MetLife Investment Advisors
Quarter-by-quarter ownership of Enliven Therapeutics (ELVN) shares owned by MetLife Investment Advisors
from 13F filings
Historical chart of MetLife Investment Advisors investment in Enliven Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Enliven Therapeutics held by MetLife Investment Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Enliven Therapeutics by MetLife Investment Advisors
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $171k | 12k | 13.84 |
| 2023-09-30 | $169k | 12k | 13.66 |
| 2023-06-30 | $252k | 12k | 20.41 |
More positions owned by MetLife Investment Advisors
View all positions for MetLife Investment Advisors